Flavonoid-mediated inhibition of intestinal ABC transporters may affect the oral bioavailability of drugs, food-borne toxic compounds and bioactive ingredients

被引:120
作者
Brand, Walter
Schutte, Maaike E.
Williamson, Gary
van Zanden, Jelmer J.
Cnubben, Nicole H. P.
Groten, John P.
van Bladeren, Peter J.
Rietjens, Ivonne M. C. M.
机构
[1] Nestec Ltd, Nestle Res Ctr, CH-1000 Lausanne 26, Switzerland
[2] Univ Wageningen & Res Ctr, Div Toxicol, NL-6700 EA Wageningen, Netherlands
[3] TNO Qual Life, Business Unit Physiol Sci, NL-3700 AJ Zeist, Netherlands
关键词
intestinal transcellular transport; ATP binding cassette (ABC) transport proteins; flavonoids;
D O I
10.1016/j.biopha.2006.07.081
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The transcellular transport of ingested food ingredients across the intestinal epithelial barrier is an important factor determining bioavailability upon oral intake. This transcellular transport of many chemicals, food ingredients, drugs or toxic compounds over the intestinal epithelium can be highly dependent on the activity of membrane bound ATP binding cassette (ABC) transport proteins, able to export the compounds. from the intestinal cells. The present review describes the ABC transporters involved in the efflux of bioactive compounds from the intestinal cells, either to the basolateral blood side, facilitating absorption, or back into the intestinal lumen, reducing bioavailability. The role of the ABC transporters in intestinal transcellular uptake also implies a role for inhibitors of these transporters in modulation of the bioavailability upon oral uptake. The present paper focuses on the role of flavonoids as important modulators or substrates of intestinal ABC transport proteins. Several examples of such an effect of flavonoids are presented. It can be concluded that flavonoid-mediated inhibition of ABC transporters may affect the bioavailability of drugs, bioactive food ingredients and/or food-borne toxic compounds upon oral uptake. All together it appears that the flavonoid-mediated interactions at the level of the intestinal ABC transport proteins may be an important mechanism for unexpected food-drug, food-toxin or food-food interactions. The overview also indicates that future studies should focus on i) in vivo validation of the flavonoid-mediated effects on bioavailability of drugs, toxins and beneficial bioactive food ingredients detected in in vitro models, and on ii) the role of flavonoid phase II metabolism in modulating the activity of the flavonoids to act as ABC transporter inhibitors and/or substrates. (c) 2006 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:508 / 519
页数:12
相关论文
共 151 条
[1]   Bioavailability and metabolism of the flavonol quercetin in the pig [J].
Ader, P ;
Wessmann, A ;
Wolffram, S .
FREE RADICAL BIOLOGY AND MEDICINE, 2000, 28 (07) :1056-1067
[2]   Dietary flavonols: Chemistry, food content, and metabolism [J].
Aherne, SA ;
O'Brien, NM .
NUTRITION, 2002, 18 (01) :75-81
[3]   Flavonoid structure-activity studies identify 6-prenyichrysin and tectochrysin as potent and specific inhibitors of breast cancer resistance protein ABCG2 [J].
Ahmed-Belkacem, A ;
Pozza, A ;
Muñoz-Martínez, F ;
Bates, SE ;
Castanys, S ;
Gamarro, F ;
Di Pietro, A ;
Pérez-Victoria, JM .
CANCER RESEARCH, 2005, 65 (11) :4852-4860
[4]  
Allen JD, 1999, CANCER RES, V59, P4237
[5]   CORRELATION BETWEEN ORAL-DRUG ABSORPTION IN HUMANS AND APPARENT DRUG PERMEABILITY COEFFICIENTS IN HUMAN INTESTINAL EPITHELIAL (CACO-2) CELLS [J].
ARTURSSON, P ;
KARLSSON, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 175 (03) :880-885
[6]   Inhibitors of multidrug resistance to antitumor agents (MDR) [J].
Avendaño, C ;
Menéndez, JC .
CURRENT MEDICINAL CHEMISTRY, 2002, 9 (02) :159-193
[7]   Analysis of ABCC6 (MRP6) in normal human tissues [J].
Beck, K ;
Hayashi, K ;
Dang, K ;
Hayashi, M ;
Boyd, CD .
HISTOCHEMISTRY AND CELL BIOLOGY, 2005, 123 (4-5) :517-528
[8]   Effect of grapefruit juice on digoxin pharmacokinetics in humans [J].
Becquemont, L ;
Verstuyft, C ;
Kerb, R ;
Brinkmann, U ;
Lebot, M ;
Jaillon, P ;
Funck-Brentano, C .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 70 (04) :311-316
[9]   MRP9, an unusual truncated member of the ABC transporter superfamily, is highly expressed in breast cancer [J].
Bera, TK ;
Iavarone, C ;
Kumar, V ;
Lee, S ;
Lee, B ;
Pastan, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (10) :6997-7002
[10]   Interaction of ochratoxin A with human intestinal Caco-2 cells: possible implication of a multidrug resistance-associated protein (MRP2) [J].
Berger, V ;
Gabriel, AF ;
Sergent, T ;
Trouet, A ;
Larondelle, Y ;
Schneider, YJ .
TOXICOLOGY LETTERS, 2003, 140 :465-476